Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional ...

CDK 4/6 inhibitors and genomics are transforming breast cancer treatment, with a focus on balancing efficacy and toxicity based on patient profiles. Comprehensive next-generation sequencing and liquid ...

Women are more likely to matriculate into medical education than men — yet they graduate at slightly lower rates. Women are also less likely to be represented in positions of leadership within the ...

Speakers at a David Geffen School of Medicine panel shared their career accomplishments and collective experiences as Black professionals in medicine Feb. 19. The Legacy We Build: Celebrating Black ...

Precision medicine is advancing rapidly, but access remains limited. Experts highlight unmet needs, how science is translated ...